Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) EBITDA (2020 - 2025)

Historic EBITDA for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $21.0 million.

  • Cellebrite DI's EBITDA rose 39.64% to $21.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $78.5 million, marking a year-over-year decrease of 4139.66%. This contributed to the annual value of $78.5 million for FY2025, which is 12782.56% up from last year.
  • According to the latest figures from Q4 2025, Cellebrite DI's EBITDA is $21.0 million, which was up 39.64% from $20.0 million recorded in Q3 2025.
  • Over the past 5 years, Cellebrite DI's EBITDA peaked at $207.9 million during Q3 2024, and registered a low of -$70.9 million during Q1 2024.
  • For the 5-year period, Cellebrite DI's EBITDA averaged around $15.8 million, with its median value being $7.8 million (2022).
  • Per our database at Business Quant, Cellebrite DI's EBITDA plummeted by 45191.64% in 2022 and then soared by 525307.4% in 2023.
  • Quarter analysis of 5 years shows Cellebrite DI's EBITDA stood at $4.3 million in 2021, then soared by 90.04% to $8.2 million in 2022, then tumbled by 270.95% to -$14.0 million in 2023, then skyrocketed by 249.68% to $20.9 million in 2024, then grew by 0.4% to $21.0 million in 2025.
  • Its EBITDA stands at $21.0 million for Q4 2025, versus $20.0 million for Q3 2025 and $21.2 million for Q2 2025.